Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists use brain scans and phones to decode addiction

NCT ID NCT02334956

First seen Jun 23, 2026 · Last updated Jun 23, 2026

Summary

This study combined brain imaging with real-world data from mobile devices to explore how addiction affects the brain. Researchers scanned the brains of 107 people with alcohol, cannabis, or nicotine dependence, along with healthy controls. They also tracked cravings and daily functioning using mobile technology. The goal was to better understand the brain processes behind addiction, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADDICTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHU de Bordeaux

    Bordeaux, 33000, France

  • Hôpital Charles Perrens

    Bordeaux, 33076, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help researchers better understand how addiction works in the brain, potentially pointing toward new ways to predict or manage cravings.

What could go wrong

This is an observational study, not a treatment trial. It is small and early-stage, so findings may not apply to everyone or lead directly to new therapies.

Conditions

The condition(s) this trial relates to.

Behavior, Addictive

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.